Amanote Research
Register
Sign In
Pcv46 - Pharmacoeconomic Evaluation and Budget Impact Analysis of Ivabradine in China
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.593
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
S. Hu
J. He
Y. Yang
Q. Kang
Publisher
Elsevier BV
Related search
Budget Impact Analysis of Vildagliptin Treating T2dm in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
On the Possibilities of Combining Budget Impact Analysis and Cost-Effectiveness Analysis - Development of «3D» Pharmacoeconomic Model
Pharmacoeconomics: theory and practice
Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pss14 - Budget Impact Analysis of Conbercept and Ranibizumab in Patients With Wet Age-Related Macular Degeneration in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Economic Evaluation and Budget Impact Analysis of Vaccination Against Haemophilus Influenzae Type B Infection in Thailand
Frontiers in Public Health
Environmental
Public Health
Occupational Health
Pharmacoeconomic Analysis of Brentuximab Vedotin Therapy in Relapsed or Refractory Cd30+ Systemic Anaplastic Large Cell Lymphoma in Patients Over 18 Years of Age: Health Budget Impact Analysis
PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
Perioperative Antibiotic Prophylaxis: Budget Impact Analysis
Vestnik of Saint Petersburg University. Medicine
Сriteria of Efficiency in Pharmacoeconomic Analysis
Pharmacoeconomics: theory and practice
Pcn80 - Budget Impact Analysis With Use of Subcutaneus Trastuzumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
